Drug & intervention
medroxyprogesterone
RxCUI 6691
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Medroxyprogesterone
Medroxyprogesterone (MP), is a progestin which is not used medically. A derivative, medroxyprogesterone acetate (MPA), is used as a medication in humans, and is far more widely known in comparison. Medroxyprogesterone is sometimes used as a synonym for medroxyprogesterone acetate, and what is almost always being referred to when the term is used is MPA and not medroxyprogesterone.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
3 shownAlzheimer's Disease: Therapeutic Potential of EstrogenNCT00066157 · 2001-09-01
COMPLETEDHormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast CancerNCT00026286 · 2000-11-28
COMPLETEDS9630, Medroxyprogesterone in Treating Women With Breast CancerNCT00002920 · 1997-03-01
COMPLETEDConditions being studied
Research locations
Ann ArborMichigan, United States2ChicagoIllinois, United States2ClevelandOhio, United States2DecaturIllinois, United States2MadisonWisconsin, United States2OmahaNebraska, United States2WichitaKansas, United States2AlbuquerqueNew Mexico, United States1AmarilloTexas, United States1AshevilleNorth Carolina, United States1AtlantaGeorgia, United States1AuroraColorado, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.